Jamie Raskin actually said...
I just think that these NDC blocks were tremendously profitable for Novartis, as they have been for other companies, and the cost is not paid by the company. It is paid by the patients, it is paid by Medicare, and all of us through increased prices.
Context
Raskin criticizes the profit model of pharmaceutical companies affecting patients' costs.
09/30/2020